1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Escilab Sp Z O O currently has 1 pending office action active in its patent portfolio. This matter is assigned to 1 distinct examiner, focusing the company's current prosecution activity. The busiest examiner for the company is ALAM, AYAAN A, who is handling the 1 pending office action.
This singular assignment indicates that the company's current engagement with the patent office is limited to a single examiner's review. For practitioners, the involvement of 1 distinct examiner means that prosecution strategy should be tailored specifically to the preferences of ALAM, AYAAN A. A precise approach is necessary to address the requirements of the pending matter effectively.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALAM, AYAAN A | 1 | 38.8% | +36.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19075147 | ORAL COMPOSITION COMPRISING B-ESCIN AND THE USE THEREOF | ALAM, AYAAN A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19075147 | ORAL COMPOSITION COMPRISING B-ESCIN AND THE USE THEREOF | ALAM, AYAAN A | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19075147 | ORAL COMPOSITION COMPRISING B-ESCIN AND THE USE THEREOF | ALAM, AYAAN A | — | §101§103§112 | Non-Final OA | — | Pending | Mar 10, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialEscilab Sp Z O O has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.
Ayaan A Alam has the most, with 1 of Escilab Sp Z O O's pending office actions.